Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Niclosamide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 9 0
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 6 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 10 1
Aprotinin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/30/2020 3 0
MK-2206 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 2 0
Excel (.xslx) CSV (.csv)